Business Parks & Science Centres



Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5658 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 26 27 28 ... 55 56 57  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
International Council of Biotechnology Associations–VCI: biotechnology, 201407 DIB is founding member of ICBA 2014-07-10
InSphero–Protea Biosciences: tissue analysis, 201407– collab product integration LAESI molecular MS imaging with 3D InSight microtissues 2014-07-09
Sophia Genetics–Endeavour Vision: investment, 201407 financing round Series B $13.75m led by Invoke Capital + Endeavour Vision + Swisscom 2014-07-08
Sophia Genetics–Invoke Capital: investment, 201407 financing round Series B $13.75m led by Invoke Capital + Endeavour Vision + Swisscom 2014-07-08
Sophia Genetics–SEVERAL: investment, 201407 financing round Series B $13.75m led by Invoke Capital + Endeavour Vision + Swisscom 2014-07-08
Analyticon Discovery–BRAIN: investment, 201407 acquisition of majority share €na by BRAIN w remaining shares held by management + key personnel 2014-07-03
Miacom Diagnostics–Fosun: investment, 201407 acquisition of 37% share by Shanghai Fosun Pharmaceutical Group 2014-07-02
Seragon Pharmaceuticals–Roche: investment, 201407– acquisition $725m upfront cash + $1b milestones by Genentech ANNOUNCED 2014-07-02
AbbVie–Apogenix: TRAIL receptor agonists, 201407 aquisition of ww rights to all TRAIL receptor agonists of Apogenix by AbbVie 2014-07-01
GeneWeave–SEVERAL: investment, 201407 financing round Series B $12m from Decheng Capital + Claremont Creek Ventures + XSeed Capital 2014-07-01
Qiagen–Altano Diagnostics: real-time PCR test, 201412– distribution ww of RealStar Ebolavirus RT-PCR Kit 1.0 by Qiagen 2014-07-01
Qiagen–Altano Diagnostics: real-time PCR test, 2014Q3– distribution of RealStar Filovirus RT-PCR Kit by Qiagen outside US 2014-07-01
Santhera–SEVERAL: investment, 201407–201408 sale CHF13.4m of 200k treasury common shares at CHF66.85/share 2014-07-01
RedHill Biopharma–Wilex: upamostat, 201406– license excl ww for Mesupron outside Greater China $1m upfront + royalties of up to 30% on net revenues 2014-06-30
Medigene–SEVERAL: investment, 201406–201407 capital increase €15.9m 3m new shares + 818.7k convertible bonds 2014-06-27
GW Pharmaceuticals–SEVERAL: investment, 201406 public offering $126.3m with 1.455m ADSs at $86.83/ADS at Nasdaq 2014-06-25
Merck (DE)–Mersana: ADC technology, 201406– collab €na using Flemixer technology to develop ADCs 2014-06-24
Agilent–Bruker Corp: chromatography data system, 201406 collab product integration exchange of instrument drivers for Compass CDS + OpenLab CDS 2014-06-23
Argen-X–SEVERAL: investment, 201406–201408 IPO €41.8m 4.7m+0.2m shares at €8.5/shares at Euronext Brussels 2014-06-23
Bayer–Dimension Therapeutics: gene therapy, 201406– collab €20m upfront + $232m milestones + royalties developm of Hemophilia A gene therapy 2014-06-23
CytoTools–Instinctif Partners: public relations, 201406 service existent by Instinctif Partners 2014-06-23
CytoTools–SEVERAL: investment, 201406 capital increase €1.7m of CytoPharma GmbH incl €0.3m from >40% owner CytoTools 2014-06-23
Definiens–SEVERAL: investment, 201406 financing round €15m led by Wellington Partners + co-led by Gilde Healthcare 2014-06-23
Dimension Therapeutics–SEVERAL: investment, 201406 financing round $30m from OrbiMed + Fidelity Biosciences 2014-06-23
Paion–SEVERAL: investment, 201406–201407 capital increase €46.26m placement of 18.5m new shares €2.5/share 2014-06-18
Bruker Corp–Max Planck: mass spectrometry s/w, 201406 collab MaxQuant proteomics s/w supporting Bruker UHR-QTOF MS with MPI Matthias Mann group 2014-06-16
Florida State Univ–Bruker Corp: FTMS magnet, 201406 supply of 21 Tesla magnet for FTC-ICR MS co-designed by NHMFL 2014-06-16
Thermo Fisher–Excellims: ion mobility spectrometer, 201406 collab co-developm + product integration of MA3100 HPIMS with Orbitrap-based MS systems 2014-06-16
Univ Copenhagen–Thermo Fisher: mass spectrometer, 201406 supply existent Jesper Olsen at NNF CPR has been early-access user of Q Exactive HF system 2014-06-16
Covidien–Medtronic: investment, 201406– acquisition $42.9b in cash + shares ANNOUNCED 2014-06-15
Merck (DE)–MorphoSys: antibody cancer drug, 201406– strategic collab €na using Ylanthia to identify MAbs against immune checkpoints in cancer 2014-06-12
Genkyotex–Halsin Partners: public relations, 201406 service existent by Halsin Partners 2014-06-11
Idenix–Merck (US): investment, 201406– acquisition $3.85b cash tender offer $24.5/share ANNOUNCED 2014-06-09
4SC–Strüngmann Group: credit, 201406–201612 loan of up to €10m w 8% interest from Santo Holding (Deutschland) GmbH 2014-06-05
Genia–Roche: investment, 201406 acquisition $125m in cash + $225m milestones ANNOUNCED 2014-06-02
B Braun–CeGaT: personalised medicine, 201406 collab establishment of B Braun CeGaT LLC in Pennsylvania 2014-06-01
Saab–Bruker Corp: analytical instruments, 201406–201511 supply chemical detectors for Saab AWR system delivered to client in Kuwait 2014-06-01
Luphos–AMETEK: investment, 201405 acquisition of Luphos GmbH by AMETEK 2014-05-30
Bayer–Argen-X: antibody technology, 201405– collab use of SIMPLE Antibody platform to discover + develop therap antibodies against Bayer targets 2014-05-28
Euprotec–Evotec: investment, 201405 acquisition 100% for £1.9m cash upfront + deferred business performace-based payment 2014-05-28
GSK–Genedata: Genedata Biologics, 201405– supply + collab GSK Biopharm RnD 2014-05-28
Roche–Stratos: DNA sequencing technology, 201405– collab r+d of SBX technology incl strategic investment by Roche 2014-05-26
Stratos–Roche: investment, 201405 strategic investment in Stratos Genomics in connection with collab on SBX technology 2014-05-26
Neuway Pharma–SEVERAL: investment, 201405 financing round Series A €2.7m led by Wellington Partners 2014-05-25
Neuway Pharma–Wellington Partners: investment, 201405 financing round Series A totalling €2.7m led by Wellington Partners 2014-05-25
Affimed–SEVERAL: investment, 201405–201409 IPO $56m+$8.4m offering 8m+1.2m common shares $7/share at Nasdaq 2014-05-23
Biobase–Qiagen: investment, 201405 acquisition €na by Qiagen 2014-05-20
Merck (DE)–Sysmex: molecular companion diagnostics, 201405– collab developm + commercialisation blood-based RAS biomarker mutation status test 2014-05-19
Bayer–Boston Scientific: investment, 201405–201409 acquisition $415m of interventional device business by Boston Scientific 2014-05-15
Co.don–SEVERAL: investment, 201405 capital increase €5m 2.6m new shares €1.9/share 2014-05-15
Thermo Fisher–Evans Analytical: ionisation technology, 201405– collab developm pulsed ion source technology for glow discharge MS 2014-05-14
Locate Therapeutics–Heraeus: investment, 201405 undisclosed investment €na by Heraeus 2014-05-09
Affymetrix–Danaher: lab automation, –201405 collab product integration fully automated ViewRNA eZ Assays on Leica BOND RX staining platform 2014-05-08
ImaginAb–SEVERAL: investment, 201405 financing round Series B $21m led by Mérieux Développement 2014-05-08
Lophius–SEVERAL: investment, 201405 financing round €2m VRD GmbH + S-Refit + another existing investor 2014-05-08
Eternygen–Evotec: drug discovery services, 201405– colllab identification + developm small-molecule inhibitors agianst target in metoblic disease 2014-05-06
Anokion–SEVERAL: investment, 201405 financing round Series A CHF33m ($37.5m) led by Novartis Venture + Novo Ventures + Versant Ventures 2014-05-05
Bayer–Cenix BioScience: drug target discovery, 201405– supply research service €na RNAi-based techn to identify targets for undisclosed indication 2014-05-05
Novartis–Ophthotech: pegpleranib, 201405– excl license + commercialisation agreem outside of US 2014-05-01
OptiBioCat project–EU (govt): grant, 201405– FP7 grant €7m to develop biocatalysts for cosmetics production 2014-05-01
Quantapore–SEVERAL: investment, 201405 financing round Series B up to $35m from undisclosed investors 2014-05-01
SomPharmaceuticals–SEVERAL: investment, 201404 private placement CHF750k Series A 2014-04-29
AllPure Technologies–Sartorius: investment, 201404– acquisition of majority stake €na by Sartorius Stedim Biotech signed 2014-04-28
CytoTools–SEVERAL: investment, 201404 capital increase €2.3m of DermaTools Biotech GmbH from mother CytoTools + existing investor 2014-04-28
Merck (US)–Agenus: antibody cancer drug, 201402– collab + license up to $100m milestones + royalties use of 4-Antibody Retrocyte Display technology 2014-04-28
Sequana Medical–SEVERAL: investment, 201404 financing round Series C CHF23m ($26.2m) led by LSP with NeoMed remaing largest investor 2014-04-28
Filgen–Metabolomic Discoveries: metabolomics, 201404– distribution excl of Metabolomic Discoveries’ technologies in Japan by Filgen 2014-04-25
Biobase–Murdoch Childrens Research Institute: POSSUMweb database, 201404– distribution ww excl by Biobase GmbH 2014-04-24
Boehringer–Hydra Biosciences: CNS drugs, 201404– collab ww r+d small-molecule TRPC4/5 inhibitors for CNS diseases 2014-04-24
Clal Industries–Hyperion Therapeutics: investment, 201404–201406 acquisition of Andromeda Biotech for $12.5m in cash + 313k shares 2014-04-24
CRISPR Therapeutics–Versant Ventures: investment, 201404 financing round Series A $25m from Versant Ventures 2014-04-24
Isarna Therapeutics–SEVERAL: investment, 201404 financing round €5.5m from existing investors incl ATNewTec + Global Asset Fonds + MIG 2014-04-24
European ScreeningPort–Fraunhofer: investment, 201406 restructuring of ESP becoming part of Fraunhofer IME 2014-04-23
GSK–Novartis: OTC drugs, 201404–201503 collab establishment of OTC joint venture with Novartis owning 36.5% 2014-04-22
Novartis–GSK: cancer drugs, 201404–201503 acquisition $14.5b + $1.5b milestones of GSK oncology products + opt in GSK oncology pipeline 2014-04-22
Novartis–GSK: investment, 201404–201503 acquisition $5.25b upfront + $1.8b milestones + royalties of Novartis vaccine business excluding flu business 2014-04-22
Novartis–Lilly: investment, 201404–201501 acquisition $5.4b in cash of Novartis Animal Health Divison by Eli Lilly 2014-04-22
High-Tech Gründerfonds–Bayer: investment, 201404 investment of Bayer Pharma AG in High-Tech Gründerfonds II 2014-04-19
Daiichi Sankyo–Max Planck: drug discovery services, 201404– supply screening services by LDC using LDC + Daiichi compound libraries 2014-04-17
4SC–EU (govt): grant, 201404– €450k grant for 4SC Discovery GmbH as part of the CV genes-at-target project 2014-04-15
Biocartis–Danaher: Evalution multiplex detection platform, 201404– collab + supply co-developm + manufacturing by Invetech 2014-04-15
Essen BioScience–SFW Capital Partners: investment, 201405 strategic investment in Essen BioScience by SFW 2014-04-15
Diana–Symrise: investment, 201404– planned acquisition €1.3b ANNOUNCED 2014-04-12
Qiagen–Austrian Academy of Sciences: biomarker, 201404– license excl ww to biomarker calreticulin (CALR) from CeMM Vienna 2014-04-10
Omni Life Science–ACEA Biosciences: cell analysis technology, 201404 collab OLS is excl distributor for ACEA in Austria 2014-04-09
Omni Life Science–ACEA Biosciences: cell analysis technology, 201404 collab OLS is excl distributor for ACEA in Germany 2014-04-09
Piqur Therapeutics–SEVERAL: investment, 201404 financing round Series A extension CHF18m led by Versant Ventures with CHF11m 2014-04-08
Piqur Therapeutics–Versant Ventures: investment, 201404 financing round Series A extension totalling CHF18m incl CHF11m from Versant Ventures 2014-04-08
Protea Biosciences–Bruker Corp: mass spectrometer, 201404 supply + installation of UltrafleXtreme MALDI TOF/TOF mass spectrometer for MS imaging 2014-04-08
IQuum–Roche: investment, 201404 acquisition $275m upfront + $175m milestones 2014-04-07
Roche–Oryzon Genomics: LSD1 inhibitors, 201404–201707 collab $21m upfront + short-term milestones + $500m milestones + royalties TERMINATED 7/17 2014-04-07
Roche–Oryzon Genomics: LSD1 inhibitors, 201605–201707 collab extension developm of ORY-1001 TERMINATED 7/17 2014-04-07
Merck (DE)–Auxogyn: IVF test, 201404– license excl for commercialisation of Eeva Test in Europe + Canada to Merck Serono 2014-04-03
Debiopharm–Evotec: drug discovery services, 201404– collab + licensing discovery + developm of cancer drugs 2014-04-02
Bayer–Targenomix: plant target discovery, 201404–201903 collab 5y to discover molecular targets in plants using systems biology 2014-04-01
EcoMetals project–BRAIN: industrial biotechnology, 201404– collab BRAIN AG is industrial project partner in German-French EcoMetals research programme 2014-04-01
EcoMetals project–Germany (govt): grant, 201404– funding €4,2m from BMBF for 7 German project partners 2014-04-01
EcoMetals project–Helmholtz: industrial biotechnology, 201404– collab HZDR is lead scientific project partner in EcoMetals research programme 2014-04-01
Pierre Fabre–Affimed: antibody technology, 201404– collab use of AbCheck’s AbSieve discovery platform to discover ABs against targets of CIPF 2014-04-01
Roche–Hitachi: immunoassay + chemical analyser, 201404–202403 collab strategic alliance developm + production 10y extension 2014-04-01
next pagenext page 1 2 3 ... 26 27 28 ... 55 56 57  next pagenext page


Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture [LSUS] – The Business Web Portal 600x60px

» top